Upload Avatar (500 x 500)
Wei Fu
wfu@fudan.edu.cn
Chinese, English
Shanghai
Fudan University
Pharmaceutical Sciences
  • 1990.07 – 1994.06 Bachelor: Jilin University, Department of Chemistry
  • 1996.09 – 2001.06 PhD: Jilin University, Institute of Theoretical Chemistry
  • 1994.08 - 1996.08 - Jilin Petrochemical Research Institute - Assistant Engineer
  • 2001.07 - 2003.09 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Postdoctoral Researcher
  • 2003.10 - 2006.09 - University of Houston, USA - Postdoctoral Researcher
  • 2006.09 - 2006.12 - Barcelona Supercomputing Center
  • 2006.12 - 2012.11 - Fudan University, School of Pharmacy - Associate Researcher, Master's Supervisor
  • 2012.11 - Present - Fudan University, School of Pharmacy - Professor, Doctoral Supervisor
  • 2023: Annual Assessment Excellence, School of Pharmacy, Fudan University
  • 2022: Annual Assessment Excellence, School of Pharmacy, Fudan University
  • 2021: Excellent Teacher, Fudan University
  • 2020: Annual Assessment Excellence, School of Pharmacy, Fudan University
  • 2020: Advanced Individual in Undergraduate Teaching, School of Pharmacy, Fudan University
  • 2020: National First-Class Online and Offline Course for 'Drug Design'
  • 2019: Advanced Individual in Undergraduate Teaching, School of Pharmacy, Fudan University
  • 2018: Dean's Award, School of Pharmacy, Fudan University
  • 2014.08: Second Prize of Science and Technology Progress Award, Chinese Pharmaceutical Association (Seventh Contributor)
  • 2012: Shanghai Municipal Excellent Course Team for 'Drug Design'
  • 2005.02: Travel Award, Fifth McLaughlin Infectious and Immunity Conference, Texas, USA
  • 2006.05: Best Work Presentation Award, Eleventh Structural Biology Annual Meeting, UTMB
  • 2005.04: 'Model Leader' Title, Summer Bachelor Training, University of South Texas
  • 2003.08: Second Prize, Ninth Shanghai Science Paper Competition
Drug Design and Discovery
Biomolecular Simulation
  • Drug design education in China, Fu, W., Li, W., Chen, B., Zhang, J., Xie, Q., Zhou, L., & Zhang, X., 2023
  • Discovery of 3-((dimethylamino)methyl)-4-hydroxy-4-(3-methoxyphenyl)-N-phenylpiperidine-1-carboxamide as novel potent analgesic, Huoming Huang, Wenli Wang, Xuejun Xu, Chen Zhu, Yujun Wang, Jinggen Liu, Wei Li, Wei Fu, 2020
  • Design, Synthesis, and Structure–Activity Relationship Studies of Novel Indolyalkylpiperazine Derivatives as Selective 5-HT1A Receptor Agonists, Wenli Wang, Lan Zheng, Wei Li, Chen Zhu, Weiqing Peng, Bing Han, Wei Fu, 2020
  • Is fragment-based graph a better graph-based molecular representation for drug design? A comparison study of graph-based models, Chen, B., Pan, Z., Mou, M., Zhou, Y., Fu, W, 2024
  • Modes of action insights from the crystallographic structures of retinoic acid receptor-related orphan receptor-γt (RORγt), Zhang, J., Chen, B., Zhang, C., Sun, N., Huang, X., Wang, W., Fu, W, 2023
Gpcr Nuclear Receptors Neuropsychiatric Diseases Autoimmune Diseases Metabolic Diseases Lead Compounds Dynamic Virtual Screening Drug Design Pain Relief Ai In Drug Design

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.